HIV patients using a mobile app are 2.9 times more likely to be adherent.
Specialty Pharmacy News
Walgreens on Tuesday announced that it has signed a definitive agreement with Madison Dearborn Partners, a leading private equity firm based in Chicago, under which MDP will acquire a majority interest in Walgreens Infusion Services.
Diplomat Pharmacy on Tuesday announced the addition of Susan Faust to their senior leadership team as VP specialty infusion and market development.
AbbVie announced that the Food and Drug Administration has approved its Duopa (carbidopa and levodopa) enteral suspension, which is used to treat motor fluctuations for people with advanced Parkinson's disease.
Walgreens on Thursday announced that effective immediately, Walgreens Infusion Services will serve as a limited network home infusion provider for Blincyto (blinatumomab).
Price Chopper launched a new specialty pharmacy program, which expands pharmacy services in an effort to provide more convenient and personalized solutions for patients.
Walgreens on Tuesday announced the launch of Well Beyond HIV, a national campaign highlighting people aging well beyond their HIV diagnosis.
Actavis on Tuesday announced the launch of a leading portfolio of generic specialty injectable medications to be marketed to hospitals across the United States.
Shire and NPS Pharmaceuticals have entered into a merger agreement for a total consideration of $5.2 billion.
Vertex Pharmaceuticals has announced that the Food and Drug Administration approved a supplemental new drug application for the use of Kalydeco (ivacaftor) in people with cystic fibrosis ages 6 years and older who have the R117H mutation in the cystic fibrosis transmembrane conductance regulator gene.